Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survey on the Treatment Reality of Patients With EGFR Mutation-positive Non-small Cell Lung Cancer

NCT02475720 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02475720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02475720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survey on the Treatment Reality of Patients With EGFR Mutation-positive Non-small Cell Lung Cancer
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 19, 2015
Completion date
March 16, 2016
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung